Exclusion Criteria:~* Patients with significant neurological disorder other than AD including hypoxia, stroke,
traumatic brain injury~* A current psychiatric disorder according the DSM-IV diagnosis of major depression
unless successfully treated on a stable dose of an antidepressant for at least 4 weeks and continues on stable
dose throughout the study~* Any other DSM-IV Axis l diagnosis including other primary neurodegenerative
dementia schizophrenia or bipolar depression~* A current diagnosis of uncontrolled diabetes mellitus (glucose
values > 200 mg/ml).~* Patients with uncontrolled diabetes will be excluded because high glucose will alter the
FDG-PET studies. The clinic that does PET (Columbia University Medical Center) excludes patients if glucose
values exceed 200 mg/ml.~* A current diagnosis of active, uncontrolled seizure disorder~* A current diagnosis
of probable or possible vascular dementia according to NINDS-AIREN~* An investigational drug during the
previous 4 weeks~* A current diagnosis of severe unstable cardiovascular disease~* A current diagnosis of acute
severe, or unstable asthmatic condition (e.g., severe chronic obstructive pulmonary disease (COPD),~* A current
diagnosis of cardiac, renal or hepatic disease~* History of alcoholism, current or within past 5 years~* A
disability that may prevent the patient from completing all study requirements (e.g., blindness, deafness,
severe language difficulty)~* A1C less than or equal to 8~* Current diagnosis of cancer/active treatments
